Dienstag JL (2010). Chronic viral hepatitis. In GL Mandell et al., eds., Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 7th ed., vol. 1, pp. 1593–1670. Philadelphia: Churchill Livingstone Elsevier.
Wiegand J, et al. (2006). Early monotherapy with pegylated interferon alfa-2b for acute hepatitis C infection: The HEP-NET Acute HCV-II Study. Hepatology, 43(2): 250–256.
Centers for Disease Control and Prevention (2012). Hepatitis C FAQs for health professionals. Available online: http://www.cdc.gov/hepatitis/HCV/HCVfaq.htm.
Ward RP, et al. (2004). Management of hepatitis C: Evaluating suitability for drug therapy. American Family Physician, 69(6): 1429–1438.
Singal AK, et al. (2010). Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis, Clinical Gastroenterology and Hepatology, 8(2): 192–199.
Pawlotsky JM, McHutchinson J (2012). Chronic viral and autoimmune hepatitis. In L Goldman, A Shafer, eds., Goldman's Cecil Medicine, 24th ed., pp. 973–979. Philadelphia: Saunders.
Bacon BR, et al. (2011). Boceprevir for previously treated chronic HCV genotype 1 infection. New England Journal of Medicine, 364(13): 1207–1217.
U.S. Food and Drug Administration (2009). Consumer advisory: Kava-containing dietary supplements may be associated with severe liver injury. Available online: http://www.fda.gov/Food/ResourcesForYou/Consumers/ucm085482.htm.
National Center for Complementary and Alternative Medicine (2012). Get the facts: Hepatitis C – A focus on herbal supplements. (NCCAM Publication No. D422). Washington,
DC: U.S. National Institutes of Health. Available online: http://nccam.nih.gov/health/hepatitisc/hepatitiscfacts.htm.
Other Works Consulted
Centers for Disease Control and Prevention (2005). Guidelines for Viral Hepatitis Surveillance and Case Management. Available online: http://www.cdc.gov/hepatitis/Statistics/SurveillanceGuidelines.htm.
Craxi A, Licata A (2006). Acute hepatitis C: In search of the optimal approach to cure. Hepatology, 43(2): 221–224.
Everson GT, et al. (2008). Quantitative tests of liver function measure hepatic improvement after sustained virological response: Results from the HALT-C trial. Alimentary Pharmacology and Therapeutics, 29(5): 589–601.
Maylin S, et al. (2008). Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C. Gastroenterology, 135(3): 821–829.
Mohsen A, Norris S (2010). Hepatitis C (chronic), search date April 2008. Online version of BMJ Clinical Evidence: http://www.clinicalevidence.com.
WebMD Medical Reference from Healthwise
July 06, 2011
This information is not intended to replace the advice of a doctor.
Healthwise disclaims any liability for the decisions you make based on this